Position in CNMD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,014
-$129,186 QoQ
Shares Held
31
-98.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#222
of 245 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CNMD Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $27,208,696 across 73 Medical Devices names. CNMD ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
149,825 | $13,595,120 | |
| 2 | SYK |
Stryker Corp
|
18,390 | $5,789,907 | |
| 3 | MDT |
Medtronic plc
|
45,296 | $3,543,506 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
11,189 | $963,261 | |
| 5 | BSX |
Boston Scientific Corp
|
13,244 | $565,253 | |
| 6 | EW |
Edwards Lifesciences Corp
|
6,100 | $551,806 | |
| 7 | MYO |
Myomo, Inc.
|
425,609 | $442,633 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
6,199 | $396,797 |
All Filings in CNMD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,014 | 31 | Shares | Sole | 2026-08-06 | |
| 2025-06-30 | $130,200 | 2,500 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $150,975 | 2,500 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $175,959 | 2,571 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $186,344 | 2,591 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $179,608 | 2,591 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,843 | 48 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,256 | 48 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,622 | 26 | Shares | Sole | 2023-11-07 | |
| No filing history on record for this holder in this stock. | ||||||